Today’s top gainers include the company GlaxoSmithKline plc (NYSE:GSK) which is in the industry Drug Manufacturers – Major, gaining -0.39% today. In the last week its performance is 1.06%, and 4.25% for the past quarter. Currently, GlaxoSmithKline plc, GSK has a target price of 48.67, so today’s gain of -0.39% is a significant step towards its target price. The GAP today is therefore -0.59%.
GlaxoSmithKline plc (NYSE:GSK), has a market cap of 106460.69, and is based in United Kingdom. Insider ownership is at 0.20%, and institutional ownership is 9.10%.
At the current price of 43.82, it has a dividend yield of 5.02%, and its target price is 48.67. This is with a profit margin of 0.10%, and total debt/equity of 34.12. GlaxoSmithKline plc (NYSE:GSK) has a P/E of 3130, as well as a forward P/E of 15.8.
With a current EPS of 0.01, and a forecasted EPS growth for next year at 6.61%,GlaxoSmithKline plc (NYSE:GSK) has had a EPS growth for the past five years at 40.20%. For the next five years EPS growth is projected to be 10.00%.
Performance for the year is 15.82%. Since its IPO date on 7/9/1986, the total performance to date is 14.82%.
Volume today for GlaxoSmithKline plc (NYSE:GSK), is 3059400, while its average volume is 3385.2. Whilst the total gain today was -0.39%, it did have a day high of -2.77%.
Volatility for this week has been at 0.86%, and 0.88% for the month. The 52-week low for GlaxoSmithKline plc, GSK has been 26.18%, while the 52-week-high has reached -2.77%.
Looking at its return of investments, which is 41.40%, and its return on assets is 0.10%. GlaxoSmithKline plc (NYSE:GSK) has an operating margin of 5.30%. With a sales growth of 10.90% quarter over quarter. Bearing in mind that GlaxoSmithKline plc, GSK is in the sector Healthcare, its long-term debt/equity is 26.3, and has a current ratio of 0.9 and 0.6 for quick ratio.
So what is the value of GlaxoSmithKline plc? Well its PEG is 313, and the P/S is 3.19, along with a P/B of 141.35. Meanwhile it has a p/cash of 17.17.